Enzo Biochem (ENZ) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Enzo Biochem Reports Fiscal Second Quarter Results
March 12, 2015 4:15 PM EDTNEW YORK--(BUSINESS WIRE)-- Enzo Biochem Inc. (NYSE: ENZ) today reported results for the fiscal second quarter ended January 31, 2015.
Year over year revenues for the quarter and first half both increased, despite persisting unusually adverse winter conditions which adversely affected the Clinical Lab. Clinical Lab revenue increased 6% for the second quarter compared to the year earlier period. Foreign currency movements impacted Life Sciences results, which otherwise would have been unchanged for the second compared to the year earlier period. Consolidated... More